Synergy CHC Corp. (NASDAQ: SNYR) Reports Strong Q1, Signals 2025 Expansion in GLP-1 and Global Markets - More Stocks Inside

Synergy CHC Corp. (NASDAQ: SNYR), a consumer health and wellness brand powerhouse, reported 30% year-over-year EPS growth and its ninth straight profitable quarter. EBITDA margin jumped to 24.1%, fueled by cost discipline and strong brand traction for FOCUSfactor and Flat Tummy.

While quarterly revenue totaled $8.2M (vs. $9.4M YoY), net income climbed to $876K. The company is preparing for international expansion and ramping up its GLP-1 support product line, targeting high-demand wellness trends.

CEO Jack Ross confirmed Synergy has secured term sheets to refinance debt through 2029, aiming to boost free cash flow and accelerate growth. With a strategic roadmap in place, SNYR is positioned for breakout momentum in 2025. Read Entire Seeking Alpha News Article Now! [https://seekingalpha.com/news/4448680-synergy-chc-gaap-eps-of-0_10-revenue-of-8_2m?utm_source=quotemedia.com&utm_medium=referral&feed_item_type=news]

Other Stocks Under $2 to Watch: Amesite Inc. (NASDAQ: AMST), Inozyme Pharma Inc. (NASDAQ: INZY), Treasure Global Inc. (NASDAQ: TGL), and Peraso Inc. (NASDAQ: PRSO). For investors focused on under-the-radar opportunities, these stocks under $2 are rapidly gaining attention along with Synergy CHC Corp. (NASDAQ: SNYR). Each company is making headlines through innovative tech, biotech breakthroughs, and strategic partnerships-positioning them as high-upside candidates in a market hungry for momentum plays.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=synergy-chc-corp-nasdaq-snyr-reports-strong-q1-signals-2025-expansion-in-glp1-and-global-markets-more-stocks-inside]
Country: United States
Website: http://www.thestreetreports.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.